The Journal of the American Medical Association contains an article detailing trends in use of prescription drugs. (JAMA Article) The data was generated from the National Health and Nutrition Examination Survey from the 1999/2000 to 2011/2012 period. In 1999/2000, 51% of adults reported use of any prescription drug in the prior 30 days. By 2011 to 2012 59% made such a report. The number of adults saying they used five or more medications rose dramatically, from 8.2% in the earlier period to 15% in 2011/2012, including 39% of adults over the age of 65. Rates of overall use and polypharmacy (five or more drugs) rose for men and women and across all adult age cohorts, but most slowly among the youngest group of adults. Hispanics showed flatter increases in medication use compared to other races or ethnicities. Among drug classes, lipid-lowering and high blood pressure medications showed the most rapid growth in prevalence of use, with anti-depressants also showing a significant rise in use. Diabetes drugs and indigestion pills also incurred over 3% increases in prevalence, while other categories like pain meds, hormones and antibiotics experienced flatter prevalence growth. Some drug use changes clearly track changes in guidelines or recommendations or FDA warnings. The rise in polypharmacy, while understandable in light of the increase in the number of older Americans with multiple chronic conditions, is alarming because there is a much greater likelihood of unpleasant interactions among medications when five or more are being taken, as well as a likelihood of adverse effects from any one of the drugs. Many of these interactions and adverse events are poorly recognized until a drug is in widespread use. This widespread polypharmacy also creates an opportunity and need for much stronger medication therapy management.
Trends in Medication Use
By Kevin RocheJanuary 15, 2016Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
CVS has finalized its $10.6 billion buyout of Oak Street health, which operates primary care centers for Medicare members. People may think CVS is a drug store company, but it...
May 4, 2023
Option Care, a large home health care provider is acquiring Amedisys, another large player in that market, for $3.6 billion, as consolidation ramps up across health care, likely meaning higher...
May 4, 2023
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
May 30, 2023
The CV-19 and Vax Lies Continue
Three pieces of misleading research or at least reporting of research indicate why science is…
May 29, 2023
Expect More of This
Minnesota's suicide rate has risen by 40% in twenty years. Democrats have been in charge…
May 29, 2023
Some Quick Climate News
CO2 and temperature have a complex relationship and the Arctic isn't going through unprecendented warmth.